CSIMarket
 


Odonate Therapeutics Inc   (ODT)
Other Ticker:  
 
 

ODT's Free Cash Flow Growth by Quarter and Year

Odonate Therapeutics Inc 's Free Cash Flow results by quarter and year




ODT Free Cash Flow (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - -31.50 -24.52 -66.15
III Quarter September -15.10 -25.15 -71.41 -0.33
II Quarter June -23.03 -28.63 -0.37 11.84
I Quarter March -24.91 -27.85 -0.33 -12.45
FY   -63.04 -113.13 -96.63 -67.09



ODT Free Cash Flow third quarter 2021 Y/Y Growth Comment
Odonate Therapeutics Inc in the third quarter 2021 recorded free cash outflow of $ -15.10 millions.

According to the results reported in the third quarter 2021, Odonate Therapeutics Inc achieved the best Free Cash Flow growth in Major Pharmaceutical Preparations industry. While Odonate Therapeutics Inc ' s Free Cash Flow no change of % ranks overall at the positon no. in the third quarter 2021.




ODT Free Cash Flow ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Odonate Therapeutics Inc 's third quarter 2021 Free Cash Flow $ -15.10 millions ODT's Income Statement
Odonate Therapeutics Inc 's third quarter 2020 Free Cash Flow $ -25.15 millions Quarterly ODT's Income Statement
New: More ODT's historic Free Cash Flow Growth >>


ODT Free Cash Flow (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Free Cash Flow third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Free Cash Flow third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Free Cash Flow by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Odonate Therapeutics Inc 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ODT's III. Quarter Q/Q Free Cash Flow Comment
Despite the fact, that Odonate Therapeutics Inc in the III. Quarter 2021 showed free cash outflow of $ -15.10 millions, it should be mentioned, that this point to improvement in contrast to the -23.03 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Odonate Therapeutics Inc achieved highest sequential Free Cash Flow growth. While Odonate Therapeutics Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ODT's III. Quarter Q/Q Free Cash Flow Comment
Despite the fact, that Odonate Therapeutics Inc in the III. Quarter 2021 admitted free cash outflow of $ -15.10 millions, it should be point out, that those numbers are recovery in contrast to the -23.03 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Odonate Therapeutics Inc achieved highest sequential Free Cash Flow growth. While Odonate Therapeutics Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Odonate Therapeutics Inc 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
Cumulative Free Cash Flow 12 Months Ending $ -94.54 $ -104.35 $ -109.76 $ -112.70 $ -105.73
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) - - - - -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Free Cash Flow growth Comment


Odonate Therapeutics Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Free Cash Flow growth Comment


Odonate Therapeutics Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Free Cash Flow Growth
Major Pharmaceutical Preparations Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
ODT's Free Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for ODT's Competitors
Free Cash Flow Growth for Odonate Therapeutics Inc 's Suppliers
Free Cash Flow Growth for ODT's Customers

You may also want to know
ODT's Annual Growth Rates ODT's Profitability Ratios ODT's Asset Turnover Ratio ODT's Dividend Growth
ODT's Roe ODT's Valuation Ratios ODT's Financial Strength Ratios ODT's Dividend Payout Ratio
ODT's Roa ODT's Inventory Turnover Ratio ODT's Growth Rates ODT's Dividend Comparisons



Companies with similar Free Cash Flow no change for the quarter ending Sep 30 2021 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Sep 30 2021
Lemaitre Vascular Inc -0.26%$ -0.262 millions
Laboratory Corporation Of America Holdings-2.40%$ -2.404 millions
Idexx Laboratories Inc-3.06%$ -3.061 millions
U S Physical Therapy Inc-4.96%$ -4.957 millions
Natus Medical Inc-4.98%$ -4.981 millions
Avantor Inc -6.96%$ -6.963 millions
Royalty Pharma Plc-7.68%$ -7.682 millions
Eli Lilly And Company-9.70%$ -9.703 millions
Ensign Group Inc-11.04%$ -11.045 millions
Meridian Bioscience Inc -11.15%$ -11.150 millions
Jrsis Health Care Corporation -12.91%$ -12.909 millions
Henry Schein Inc-15.29%$ -15.288 millions
Tivity Health Inc -15.34%$ -15.340 millions
Dentsply Sirona Inc -16.95%$ -16.948 millions
National Research Corporation-17.23%$ -17.231 millions
Strata Skin Sciences Inc -17.67%$ -17.668 millions
Nuvasive Inc-18.38%$ -18.375 millions
Vericel Corporation-20.48%$ -20.481 millions
Adapthealth Corp -20.87%$ -20.867 millions
Addus Homecare Corporation-21.43%$ -21.435 millions
Abiomed Inc -21.55%$ -21.548 millions
Biodelivery Sciences International Inc -22.44%$ -22.438 millions
Nature s Sunshine Products inc -23.01%$ -23.011 millions
3m Company-24.44%$ -24.435 millions
Amedisys Inc -25.66%$ -25.656 millions
United Therapeutics Corporation-26.03%$ -26.026 millions
Select Medical Holdings Corp-26.45%$ -26.448 millions
Bio techne Corp-26.63%$ -26.625 millions
Tenet Healthcare Corp-27.15%$ -27.150 millions
Boston Scientific Corporation-27.68%$ -27.683 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com